144 related articles for article (PubMed ID: 16898009)
1. [The possibility of S-1 for the treatment of patients with urological cancers].
Akaza H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():236-8. PubMed ID: 16898009
[TBL] [Abstract][Full Text] [Related]
2. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Ajani JA
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
[TBL] [Abstract][Full Text] [Related]
4. [Clinical benefit of S-1 in metastatic breast cancer].
Saeki T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
[TBL] [Abstract][Full Text] [Related]
5. [S-1 for treatment of breast cancers].
Saeki T; Takashima S
Nihon Rinsho; 2000 Apr; 58 Suppl():284-91. PubMed ID: 11026008
[No Abstract] [Full Text] [Related]
6. [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Funakoshi A; Senju T; Sumii T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1505-9. PubMed ID: 17033248
[TBL] [Abstract][Full Text] [Related]
7. [Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report].
Mizuno N; Sawaki A; Yamao K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1511-4. PubMed ID: 17033249
[TBL] [Abstract][Full Text] [Related]
8. [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Amano A; Ohkawa S; Ueno M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1307-9. PubMed ID: 17687220
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1311-4. PubMed ID: 17687221
[TBL] [Abstract][Full Text] [Related]
10. [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Ikeda M; Ueno H
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1515-9. PubMed ID: 17033250
[TBL] [Abstract][Full Text] [Related]
11. Multicenter phase II trial of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Eto M; Shinohara N; Tomita Y; Fujisawa M; Namiki M; Nishikido M; Usami M; Tsukamoto T; Akaza H
J Clin Oncol; 2010 Dec; 28(34):5022-9. PubMed ID: 20975067
[TBL] [Abstract][Full Text] [Related]
12. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Lenz HJ; Lee FC; Haller DG; Singh D; Benson AB; Strumberg D; Yanagihara R; Yao JC; Phan AT; Ajani JA
Cancer; 2007 Jan; 109(1):33-40. PubMed ID: 17133415
[TBL] [Abstract][Full Text] [Related]
13. [Phase I study of concurrent radiotherapy with S-1 for oral squamous cell carcinoma].
Sato M; Harada K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():179-83. PubMed ID: 16897998
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
17. [TS-1 and irradiation combination therapy for head and neck cancer].
Kawasaki M; Watanabe K; Watanabe J
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1077-80. PubMed ID: 16912525
[TBL] [Abstract][Full Text] [Related]
18. [Progress in oral anti-cancer drug therapy for urological cancer].
Tsukamoto S; Akaza H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):308-14. PubMed ID: 10065093
[TBL] [Abstract][Full Text] [Related]
19. [Severe advanced lower gingival carcinoma effectively reduced by chemoradiation with S-1--report of a case].
Ishibashi M; Masuda N; Noguchi K; Moridera K; Nishimura N; Takayama T; Nishioji K; Urade M; Kogo M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1837-9. PubMed ID: 18030019
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of oral fluoropyrimidine derivative S-1 and radiation on human hypopharyngeal cancer xenografts.
Nakagawa T; Otsuki N; Masai Y; Sasaki R; Tsukuda M; Nibu K
Acta Otolaryngol; 2008 Aug; 128(8):936-40. PubMed ID: 18607998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
